GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 5,166 shares, an increase of 47.9% from the July 15th total of 3,493 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 11,239 shares, the days-to-cover ratio is currently 0.5 days.
Institutional Investors Weigh In On GMO U.S. Value ETF
A number of institutional investors have recently added to or reduced their stakes in the business. Pathway Financial Advisors LLC acquired a new position in GMO U.S. Value ETF in the 2nd quarter valued at approximately $246,000. Essential Partners LLC grew its stake in shares of GMO U.S. Value ETF by 8.6% in the first quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after purchasing an additional 4,774 shares during the last quarter. Fifth Third Bancorp acquired a new stake in GMO U.S. Value ETF in the first quarter valued at $84,000. Kestra Private Wealth Services LLC acquired a new stake in GMO U.S. Value ETF in the first quarter valued at $333,000. Finally, MML Investors Services LLC bought a new position in GMO U.S. Value ETF during the 4th quarter worth $1,794,000.
GMO U.S. Value ETF Price Performance
GMOV stock traded up $0.20 during midday trading on Tuesday, reaching $32.48. 8,807 shares of the stock were exchanged, compared to its average volume of 16,244. The stock has a market capitalization of $103.94 million, a PE ratio of 12.08 and a beta of 0.62. The company has a fifty day moving average price of $30.89 and a 200 day moving average price of $29.72. GMO U.S. Value ETF has a 52 week low of $25.66 and a 52 week high of $32.70.
GMO U.S. Value ETF Company Profile
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Further Reading
- Five stocks we like better than GMO U.S. Value ETF
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
